Has my stock been accused of fraud?Join over 160k users who know.

Ticker Price Change($) Change(%) Shares Volume Prev Close Open Gain($) Gain(%)
Ticker Status Jurisdiction Filing Date CP Start CP End CP Loss Deadline
Ticker Case Name Status CP Start CP End Deadline Settlement Amt
Ticker Name Date Analyst Firm Up/Down Target ($) Rating Change Rating Current

News

JP Morgan Initiates Coverage On Amrize with Overweight Rating, Announces Price Target of $57

Author: Benzinga Newsdesk | July 15, 2025 07:04am
JP Morgan analyst Adrian Huerta initiates coverage on Amrize (NYSE:AMRZ) with a Overweight rating and announces Price Target of $57.

Posted In: AMRZ

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION

CORE Finalist